Abstracts tagged "Biologics and spondylarthropathy"

Abstract Number: 2857 • ACR/ARHP Annual Meeting 2015
The 8-Year Retention Rate of the First TNF-Inhibitor in the Treatment of Spondyloarthropathies: Real-Life Data from Three Local Registries
Ennio Giulio Favalli¹, Andrea Becciolini¹, Martina Biggioggero², Enrico Fusaro³, Simone Parisi³, Alarico Ariani⁴, Daniele Santilli⁴, Antonio Marchesoni¹ and Pier Luigi Meroni², ¹Department of Rheumatology, Gaetano Pini Institute, Milan, Italy, ²University of Milan, Department of Clinical Sciences and Community Health, Division of Rheumatology, Gaetano Pini Institute, Milan, Italy, ³Città della salute e della Scienza, Turin, Italy, ⁴Department of Internal Medicine and Rheumatology, University of Parma, Parma, Italy
Background/Purpose: Long-term data on drug survival of TNF inhibitors (TNFi) in the treatment of spondyloarthropathies are still lacking. The aim of the study is to…